Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Title
Intervention Indication Therapeutic Area Year Actions
Marstacimab for the treatment of haemophilia A and haemophilia B Marstacimab (PF-06741086) Haemophilia A , Haemophilia B Haematology 2023 View  |  Download
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders Mexiletine hydrochloride (Namuscla) Myotonia Genetic Disorders 2023 View  |  Download
Mim8 for prophylaxis of haemophilia A NNC0365-3769 Haemophilia A Haematology 2023 View  |  Download
Mirvetuximab soravtansine for advanced, epithelial ovarian, fallopian tube, or primary peritoneal cancer with high folate receptor-alpha expression Mirvetuximab soravtansine (IMGN853) Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2023 View  |  Download
Neoadjuvant nivolumab with gemcitabine and cisplatin followed by adjuvant nivolumab for previously-untreated muscle-invasive bladder cancer Cisplatin (Platinol) , Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Bladder cancer Urological Cancer 2023 View  |  Download
Nipocalimab for Generalised Myasthenia Gravis Nipocalimab Myasthenia gravis (MG) Musculoskeletal System 2023 View  |  Download
Niraparib as maintenance therapy for treating recurrent or primary-advanced endometrial cancer after chemotherapy in combination with dostarlimab. Chemotherapy , Dostarlimab (TSR-042; Jemperli) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) Endometrial cancer Female Reproductive Cancer 2023 View  |  Download
Niraparib with pembrolizumab maintenance therapy for metastatic stage III or IV non-small cell lung cancer Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) , Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Nivolumab adjuvant therapy for renal cell carcinoma Nivolumab (Opdivo; BMS-936558; ONO-4538) Renal cell carcinoma (RCC) Renal Cancer 2023 View  |  Download
NVK-002 for myopia in children NVK-002 Myopia Ophthalmology 2023 View  |  Download
1 2 8 9 10 11 12 18 19
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications